Sunmax Biotechnology Co Ltd (4728) — Cash Flow Quality Index
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Quality Index of 0.85x as of September 2025. Operating cash flow of NT$160.84 Million is below net income of NT$189.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Sunmax Biotechnology Co Ltd (4728) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sunmax Biotechnology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Sunmax Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sunmax Biotechnology Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Sunmax Biotechnology Co Ltd. For live market cap and the full company financial profile, see Sunmax Biotechnology Co Ltd (4728) market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | NT$397.37 Million | NT$679.40 Million | ▼ -37.3% |
| 2023 | 0.93x | NT$848.56 Million | NT$909.39 Million | ▲ +45.2% |
| 2022 | 0.64x | NT$342.97 Million | NT$533.83 Million | ▼ -5.6% |
| 2021 | 0.68x | NT$243.28 Million | NT$357.49 Million | ▼ -40.6% |
| 2020 | 1.15x | NT$386.97 Million | NT$337.76 Million | ▼ -60.2% |
| 2019 | 2.88x | NT$289.51 Million | NT$100.45 Million | ▲ +113.4% |
| 2018 | 1.35x | NT$100.83 Million | NT$74.66 Million | ▼ -39.8% |
| 2017 | 2.24x | NT$37.09 Million | NT$16.54 Million | ▼ -76.4% |
| 2016 | 9.51x | NT$16.58 Million | NT$1.74 Million | — |